Cannabis — Oct 5 – Oct 9, 2026 (Wk 41): Tilray’s Record Revenue Masks Cannabis Sales Dip; Aurora Drama Heats Up

TL;DR — Tilray Brands reported record quarterly revenue, but its cannabis sales declined, leading to a stock price drop. Meanwhile, other cannabis companies like Aurora and Cresco Labs saw varied stock movements amid ongoing industry developments and investor scrutiny.

What moved

• Tilray Brands reported record Q1 2027 revenue, but its shares fell following the announcement. This suggests that while overall revenue grew, the market may have focused on other aspects of the earnings, such as a reported shrinking in cannabis sales, which could impact investor confidence in the core cannabis business. (src: [1, 4]) [Investing.com Nigeria] [24/7 Wall St.]
• Aurora Cannabis experienced increased market attention this week, with headlines suggesting 'drama heats up.' The specific nature of this drama is not detailed in our sources, but such developments can introduce volatility and uncertainty for investors in the company. (src: [0, 4]) [Stockhouse] [24/7 Wall St.]
• Cresco Labs' stock rose 2.20% as investors awaited a key rescheduling deadline and a Q3 update. This indicates that potential regulatory changes and upcoming financial disclosures are significant catalysts that can influence stock performance in the cannabis sector. (src: [13]) [kalkine.ca]
• SNDL announced the immediate resignation of director Carlo Cannell. Changes in board composition can sometimes signal shifts in corporate strategy or governance, which may be observed by the market. (src: [14]) [The Globe and Mail]
• Vireo Growth and Cannara Biotech stocks faced fresh pressure, with concerns about execution and valuation risks for Vireo, and general cannabis volatility testing investor confidence for Cannara. This highlights that even with industry expansion, individual company performance and market sentiment can lead to downside pressure. (src: [11, 12]) [kalkine.ca] [kalkine.ca]

The why behind the week

• The cannabis sector continues to experience volatility, with individual company news, such as earnings reports and director resignations, driving stock movements. For example, Tilray's record revenue was overshadowed by a decline in cannabis sales, indicating that investors are scrutinizing the underlying health of the core business rather than just top-line growth. (src: [1, 4, 11, 12, 14]) [Investing.com Nigeria] [24/7 Wall St.] [kalkine.ca] [kalkine.ca] [The Globe and Mail]
• Anticipation of regulatory changes, such as rescheduling deadlines, and upcoming financial reports are significant factors influencing stock prices. The rise in Cresco Labs' stock ahead of a rescheduling deadline suggests that potential policy shifts are seen as important catalysts for the industry. (src: [13]) [kalkine.ca]
• Investor attention is also drawn to specific companies like Trulieve Cannabis, though our sources do not provide a clear catalyst for this renewed interest this week. This suggests that ongoing market analysis and investor sentiment can drive attention even without explicit news. (src: [6, 15]) [Simply Wall Street] [Upstox]

📄 Filings that matter (8-Ks, straight from EDGAR)

• $TLRY — reported results (earnings 8-K) [SEC filing] 2026-10-08
• $GNLN — bankruptcy or receivership; completed an acquisition or disposition [SEC filing] 2026-10-07

The macro backdrop

Every theme swims in this tide — judge the week’s moves against it.

What to watch next

• The median price-to-model-value across 13 cannabis stocks is 1.15x (own). This metric indicates how current market prices compare to a calculated intrinsic value, and changes in this ratio can signal shifts in market perception of value within the theme. [SAVNG data]
• Upcoming earnings reports and key regulatory deadlines, such as the one awaited by Cresco Labs, will be important to monitor. These events can provide clarity on company performance and potential industry shifts, which can influence stock valuations. (src: [13]) [kalkine.ca]
• There were no recorded open-market insider buys (routine/10b5-1 stripped) in the cannabis theme this week (own). Insider buying can sometimes be interpreted as a signal of confidence from those closest to a company, so its absence may be noted by the market. [SAVNG data]

This week’s headlines (sources)

• StockTalk | Cannabis Report: The Aurora drama heats up | 2026-10-09 | Investing News — Stockhouse, Oct 9
• Earnings call transcript: Tilray posts record Q1 2027 revenue as shares fall — Investing.com Nigeria, Oct 8
• Promising Cannabis Stocks To Research – October 8th — MarketBeat, Oct 8
• How Preferred Stock Offering Will Impact IIP Investors — Simply Wall Street, Oct 8
• Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease — 24/7 Wall St., Oct 8
• Bill Ackman Says He Wasn’t Blaming Retail Investors For PSUS Stock’s Post-IPO Tumble: ‘I Was Simply Explaining…’ — Stocktwits, Oct 8
• What Is Drawing Fresh Attention To Trulieve Cannabis (TRLV)? — Simply Wall Street, Oct 8
• Rivian Stock Slides Overnight: Investors Look Past R2 Buzz To Amazon’s Growing Grip On Auto Revenue — Stocktwits, Oct 7
• Tilray Brands stock analysis ahead of earnings: will it rebound or fall further? — Invezz, Oct 7
• Top 3 Canadian Healthcare Stocks To Watch In October 2026 — Simply Wall Street, Oct 7
• Industry News And Stocks To Watch — Investor's Business Daily, Oct 7
• Vireo Growth Stock Faces Fresh Pressure as Cannabis Expansion Raises Execution and Valuation Risks — kalkine.ca, Oct 7
• Cannara Biotech Stock Faces Downside Pressure as Cannabis Volatility Tests Investor Confidence — kalkine.ca, Oct 7
• Cresco Labs Stock Rises 2.20% as Cannabis Investors Await Key Rescheduling Deadline and Q3 Update (CN:CL) — kalkine.ca, Oct 7
• SNDL Announces Immediate Resignation of Director Carlo Cannell — The Globe and Mail, Oct 7
• Trulieve Cannabis Corp. Share Price Live Today – NYSE:TRLV Stock Price, Chart, News, History — Upstox, Oct 7

Every claim above cites its source — headlines link to the original outlet; [SAVNG data] marks our own EDGAR-computed figures. Where our sources don’t explain a move, we say so rather than guess. All weekly roundups →